| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 09/12/2003 | WO2003041684A3 Injectable depot compositions and uses thereof |
| 09/12/2003 | WO2003034987A3 Androgen receptor modulators and methods of use thereof |
| 09/12/2003 | WO2002080979A3 Conjugate of hydroxyalkyl starch and an active agent |
| 09/12/2003 | WO2002032961A8 Novel polypeptides and nucleic acids encoding same |
| 09/12/2003 | CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 09/12/2003 | CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 09/12/2003 | CA2477075A1 Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 09/11/2003 | WO2003074449A2 Multi-substitued selective androgen receptor modulators and methods of use thereof |
| 09/11/2003 | WO2003074075A1 Pharmaceutical and cosmetic compositions comprising plgf-1 |
| 09/11/2003 | US20030171428 Anticancer agents; anticholesterol agents; cognition activators; rheumatic diseases |
| 09/11/2003 | US20030171411 Amide derivatives as therapeutic agents |
| 09/11/2003 | US20030171389 Anticancer agents; bone disorders; antiarthritic agents |
| 09/11/2003 | US20030171354 Indole derivatives |
| 09/11/2003 | US20030171342 Novel 16-ene-C25-oxime and 16-ene- C-25-oxime ether analogs of 1 alpha ,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24. |
| 09/11/2003 | US20030171299 Stable, biologically compatible pharmaceutical compositions in the form of water-in-oil microemulsions (w/o), for the sustained release by parenteral administration of active ingredients which are hydrophilic or are made hydrophilic by |
| 09/11/2003 | US20030171278 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 09/11/2003 | US20030171267 Albumin fusion proteins |
| 09/11/2003 | US20030170292 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 09/11/2003 | US20030170289 Injectable depot compositions and uses thereof |
| 09/10/2003 | EP1342489A1 Method of affecting sleep and sleep-related behaviors |
| 09/10/2003 | EP1342476A2 FGFR3 as a marker for mesenchymal skeletal progenitor cells and use of cytotoxic conjugates comprising an FGFR3 binding agent for the treatment of cartilagineous bony tumours |
| 09/10/2003 | EP1342469A2 Stable glass state powder formulations |
| 09/10/2003 | EP1342410A2 Transgenic animals lacking a functional galanin gene |
| 09/10/2003 | EP1341793A2 Crf receptor antagonists and methods relating thereto |
| 09/10/2003 | EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 09/10/2003 | EP1341549A2 Combination therapy for estrogen-dependent disorders |
| 09/10/2003 | EP1341533A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/10/2003 | CN1441787A Modulators of TNF-alpha signaling |
| 09/10/2003 | CN1441666A Macromolecular drug complexes and compositions containing same |
| 09/10/2003 | CN1120846C Somatotropin releasing peptide and its application |
| 09/09/2003 | US6617426 Peptide analogs of given formula; useful in treating neurodegenerative, autoimmune, cognitive disorders, stroke and traumatic injury |
| 09/09/2003 | US6617360 Medical treatment |
| 09/09/2003 | US6617359 4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical |
| 09/09/2003 | US6616951 Fermented herbal drink |
| 09/09/2003 | CA2263566C Substituted 6,5-hetero-bicyclic derivatives |
| 09/09/2003 | CA2248953C Novel benzofuranone derivatives and process for producing the same |
| 09/04/2003 | WO2003072779A1 Method of using pituitary-specific genes |
| 09/04/2003 | WO2003072735A2 Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 09/04/2003 | WO2003072592A1 17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents |
| 09/04/2003 | WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/04/2003 | WO2003072195A2 Method for administering glp-1 molecules |
| 09/04/2003 | WO2003072110A1 Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases |
| 09/04/2003 | WO2003072109A1 Use of biogenic estriol sulfamate prodrugs for the treatment of autoimmune diseases |
| 09/04/2003 | WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones |
| 09/04/2003 | WO2003051805A3 Substituted phenyl naphthalenes as estrogenic agents |
| 09/04/2003 | WO2002064792A3 Molecules for disease detection and treatment |
| 09/04/2003 | WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 09/04/2003 | WO2002015892A3 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors |
| 09/04/2003 | WO2001066595A9 Human fgf-23 gene and gene expression products |
| 09/04/2003 | WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 09/04/2003 | US20030166944 TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme |
| 09/04/2003 | US20030166838 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives |
| 09/04/2003 | US20030166730 Amide derivatives for the treatment of diseases mediated by cytokines |
| 09/04/2003 | US20030166725 Compounds active at the glucocorticoid receptor |
| 09/04/2003 | US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 09/04/2003 | US20030166690 Use of compounds for decreasing activity of hormone-sensitive |
| 09/04/2003 | US20030166689 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/04/2003 | US20030166657 Treating an optically pure enantimer of zopiclone with 1-chloroethyl chloroformate or an azodicarboxylate followed hydrolysis; modulation of benzodiazepine receptors; sleep and behavioral disorders; anxiolytic agents |
| 09/04/2003 | US20030166653 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 09/04/2003 | US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/04/2003 | US20030166641 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders |
| 09/04/2003 | US20030166632 Method for treating a disease or condition responsive to opening of C1C-2 channel |
| 09/04/2003 | US20030166588 Splice-region antisense composition and method |
| 09/04/2003 | US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions |
| 09/04/2003 | US20030166534 Suppressing a class II MHC-restricted immune response in a mammal, or in mammalian cells, are described. The methods depend upon inhibiting invariant chain proteolysis by cathepsin S from class II MHC/invariant chain complexes, |
| 09/04/2003 | US20030166228 Anti-interferon-alpha antibodies |
| 09/04/2003 | US20030166189 Peptide of given amino acid sequence; sulfotransferases; useful in labeling agents with tagged sulfur, diagnosis/treatment of cancer, hypertension, renal and neurodegenerative diseases |
| 09/04/2003 | US20030165930 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof |
| 09/04/2003 | US20030165892 Unigene unidirectional antisense library |
| 09/04/2003 | US20030165569 Composition for topical substance delivery |
| 09/04/2003 | US20030165499 Compositions and methods for treating psoriasis |
| 09/04/2003 | CA2477038A1 Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 09/04/2003 | CA2477008A1 Substituted pyrimidinones and pyrimidinthiones |
| 09/04/2003 | CA2473340A1 Formulations comprising a glp-1 compound and a delivery agent, and uses thereof |
| 09/03/2003 | EP1340503A1 Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery |
| 09/03/2003 | EP1339714A1 Novel sulfonamide-substituted pyrazolopyridine derivatives |
| 09/03/2003 | EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands |
| 09/03/2003 | EP1339683A2 Estrogen receptor modulators |
| 09/03/2003 | EP1339431A1 Improved oral delivery of peptides using enzyme-cleavable membrane translocators |
| 09/03/2003 | EP1339406A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 09/03/2003 | EP1339387A2 Stable, aerosolizable suspensions of proteins (e.g. insulin, dnase) in ethanol |
| 09/03/2003 | EP1095038B1 Antagonists of gonadotropin releasing hormone |
| 09/03/2003 | EP1070065B1 Azabicyclic 5ht1 receptor ligands |
| 09/03/2003 | EP0876359B1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 09/03/2003 | EP0775156B1 Pharmaceutical compositions containing estra-1,3,5(10)-triene derivatives |
| 09/03/2003 | CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 09/03/2003 | CN1440411A Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 09/03/2003 | CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/03/2003 | CN1440391A Propane-1,3-dione derivatives |
| 09/03/2003 | CN1440383A PPARγ调制剂 PPARγ modulators |
| 09/03/2003 | CN1440283A Combination of organic compounds |
| 09/03/2003 | CN1440282A Improved thyroid hormone formulations |
| 09/03/2003 | CN1439673A High friction coefficient rubber composite brake shoes |
| 09/03/2003 | CN1439375A 脱氢表雄酮的治疗用途和传送系统 DHEA therapeutic uses and delivery systems |
| 09/03/2003 | CN1439367A Pratensein extraction and preparation thereof |
| 09/03/2003 | CN1120162C Novel benzopyran derivatives |
| 09/03/2003 | CN1119998C Compressed dry-granulation desogestrel tablets |
| 09/02/2003 | US6615066 Gastrointestinal probe |
| 09/02/2003 | US6613874 Melanocortin receptor ligands |
| 09/02/2003 | US6613802 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |